INDOUS
Start SIP
Invest Now
Start SIP in INDOUS
Performance
- Low
- ₹127
- High
- ₹132
- 52 Week Low
- ₹110
- 52 Week High
- ₹388
- Open Price₹132
- Previous Close₹129
- Volume33,890
Investment Returns
- Over 1 Month -2.07%
- Over 3 Month -12.03%
- Over 6 Month -21.4%
- Over 1 Year -54.78%
Smart Investing Starts Here Start SIP with Indo US Bio-Tech for Steady Growth!
Indo US Bio-Tech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 15.2
- PEG Ratio
- 0.3
- Market Cap Cr
- 257
- P/B Ratio
- Average True Range
- 10.44
- EPS
- 8.43
- Dividend Yield
- 0
- MACD Signal
- -1.16
- RSI
- 48.59
- MFI
- 80.24
Indo US Bio-Tech Financials
Indo US Bio-Tech Technicals
EMA & SMA
Current Price
₹128.00
-1.1
(-0.85%)
- Bearish Moving Average 0
- Bullish Moving Average 0
- 20 Day
- ₹129.96
- 50 Day
- ₹133.64
- 100 Day
- ₹142.48
- 200 Day
- ₹161.02
Resistance and Support
129.03
- R3 135.52
- R2 133.58
- R1 130.97
- S1 126.42
- S2 124.48
- S3 121.87
Indo US Bio-Tech Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-10-14 | Others | Inter-alia, to consider 1. Re-appointment of M/s. Gautam N Associates as a Statutory Auditors of the Company. 2. Approve Notice of Postal Ballot. 3. Other business matters. per share(2.5%)Interim Dividend |
| 2025-08-12 | Quarterly Results | |
| 2025-05-26 | Audited Results | |
| 2025-02-11 | Quarterly Results |
Indo US Bio-Tech F&O
About Indo US Bio-Tech
- NSE Symbol
- INDOUS
- BSE Symbol
- 541304
- Managing Director
- Mr. Jagdish Ajudia
- ISIN
- INE250Z01010
Similar Stocks to Indo US Bio-Tech
Indo US Bio-Tech FAQs
Indo US Bio-Tech share price is ₹128 As on 07 December, 2025 | 23:27
The Market Cap of Indo US Bio-Tech is ₹256.7 Cr As on 07 December, 2025 | 23:27
The P/E ratio of Indo US Bio-Tech is 15.2 As on 07 December, 2025 | 23:27
The PB ratio of Indo US Bio-Tech is 3.7 As on 07 December, 2025 | 23:27
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.